A Simple Automated Method for Detecting Recurrence in High-Grade Glioma
T K Yanagihara1, J Grinband2, J Rowley3
1From the Departments of Radiation Oncology (T.K.Y., J.R., A.L., M.G., M.A., A.C., T.J.C.W.) tky2102@columbia.edu.
AJNR. American Journal of Neuroradiology
|July 16, 2016
Summary
An automated multiparametric MRI analysis effectively identifies recurrent high-grade glioma. This method uses subtraction maps from routine imaging to predict tumor progression, aiding treatment planning for patients with high-grade glioma.
Area of Science:
- Neuroimaging
- Oncology
- Radiology
Background:
- High-grade gliomas often recur, necessitating accurate identification of recurrent disease for effective management.
- Current methods for detecting recurrence can be subjective and time-consuming.
- Focal re-irradiation requires precise localization of recurrent tumor areas.
Purpose of the Study:
- To develop and validate an automated multiparametric MRI analysis for identifying focally recurrent high-grade glioma.
- To assess the utility of this automated method in guiding treatment decisions for recurrent gliomas.
- To establish a tool for improved treatment planning and post-treatment surveillance.
Main Methods:
- Retrospective review of MRI data (T1WI, FLAIR, DWI) from 141 patients with high-grade glioma treated with radiation therapy.
- Development of automated multiparametric subtraction maps to identify patterns of change indicative of recurrence.
- Validation of the method in a cohort of 12 patients with nodular recurrence and assessment in a separate cohort of 4 patients treated with radiosurgery.
Main Results:
- Automated subtraction maps accurately predicted radiologist-identified recurrence in cohort 1 (median AUC = 0.91).
- The model correctly identified recurrent lesions in cohort 2, guiding treatment decisions.
- In cohort 2, treated lesions showed control, while untreated progressing lesions aligned with model predictions.
Conclusions:
- Automated multiparametric MRI subtraction maps can reliably predict nodular progression in previously treated high-grade gliomas.
- This automated approach, utilizing routine imaging sequences, offers a valuable tool for clinical decision-making.
- Prospective validation is recommended for treatment planning and surveillance of high-grade glioma recurrence.


